Peptide TherapeuticsPeer Reviewed

Quantifying depression and the risk of chronic liver diseases: results from a large-scale longitudinal cohort study.

Authors (4)
Hailiang WangDepartment of Hepatobiliary Surgery, Zibo First Hospital, Zibo, Shandong, China.
Shuju ZhaoShandong Daizhuang Hospital, Jining, China.
Xueqing WangShengjing Hospital of China Medical University, Shenyang, China.
Xiaoyang LiuWest China Hospital, Sichuan University, Chengdu, China.
Frontiers in public health
Unknown
Published
Jan 01, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

CHARLSchronic liver diseasesdepressionolder adultsrisk factors

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics